Saks Samuel R 4
4 · Protagonist Therapeutics, Inc · Filed May 31, 2018
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2018-05-31+50,000→ 50,000 totalExercise: $7.28Exp: 2028-05-30→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of May 21, 2018, and 1/36th of the remaining shares subject to the option vesting each month.